en

PRODUCT DETAIL

Xonvea 20 mg/20 mg tablety s riadeným uvoľňovaním

Code 3341E
MA number 20/0084/23-S
Product Form: tbl mod 40x20 mg/20 mg (blis.OPA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 20 - ANTIEMETICA, ANTIVERTIGINOSA
ATC:
R RESPIRATORY SYSTEM
R06 ANTIHISTAMINES FOR SYSTEMIC USE
R06A ANTIHISTAMINES FOR SYSTEMIC USE
R06AA Aminoalkyl ethers
R06AA59 Doxylamine,combinations
Shelf life: 48
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - known active substance
MA issued: 18.04.2023
Validity: 18.04.2028
SPC: SPC_Xonvea 20 mg_20 mg tablety s riadeným uvoľňovaním_03 2023.pdf  
PIL: PIL_Xonvea 20 mg_20 mg tablety s riadeným uvoľňovaním_08 2023.pdf  
Safety feature Yes
Data update: 26.04.2023
eu-flag.png sk-flag.png